Homepage | Lupus Science & Medicine
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
About | Lupus Science & Medicine
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
Mouse models of lupus: what they tell us and what they don’t
2018年1月20日 · Lupus is a complex heterogeneous disease characterised by autoantibody production and immune complex deposition followed by damage to target tissues. Animal …
Renal response status to predict long-term renal survival in …
1 天前 · Objective To evaluate modified versions of the Belimumab International Study in Lupus Nephritis (BLISS-LN) belimumab study primary efficacy renal response (mPERR) and …
Most Read Articles | Lupus Science & Medicine
2024年1月19日 · Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela …
Top cited articles | Lupus Science & Medicine
Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 …
Achieving remission or low disease activity is associated with …
2021年9月20日 · Background Remission and low disease activity (LDA) have been proposed as the treatment goals for patients with systemic lupus erythematosus (SLE). Several definitions …
Global consensus building and prioritisation of fundamental lupus ...
2019年7月18日 · Objective Lupus is a complex, heterogeneous autoimmune disease that has yet to see significant progress towards more timely diagnosis, improved treatment options for …
Efficacy and safety of telitacicept in patients with systemic lupus ...
2023年11月23日 · Objective To examine the efficacy and safety of telitacicept in the treatment of patients with SLE in everyday clinical practice.Methods Seventy-two patients with active SLE …
Table of contents | Lupus Science & Medicine
2014年4月4日 · Original research: Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse (24 April, 2023)